The ret oncogene products are membrane-bound glycoproteins phosphorylated on tyrosine residues in vivo
Authors:
- Takashi IwamotoTITakashi Iwamoto
- Michinari HamaguchiMHMichinari Hamaguchi
- Mutsushi MatsuyamaMMMutsushi Matsuyama
- Masahide TakahashiMTMasahide Takahashi
- 1 November 1991
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 181 (1) , 416-422
Abstract
No abstract availableKeywords
Funding Information
- RIKEN
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 6 references indexed in Scilit:
- Preferential development of pre‐B lymphomas with drastically down‐regulated N‐myc in the Eμ‐ret transgenic miceEuropean Journal of Immunology, 1991
- cDNA cloning of a Novel 85 kd protein that has SH2 domains and regulates binding of PI3-kinase to the PDGF β-receptorCell, 1991
- Molecular bases of dominant negative and loss of function mutations at the murine c‐kit/white spotting locus: W37, Wv, W41 and W.The EMBO Journal, 1990
- cDNA cloning and characterization of ret activated in a human papillary thyroid carcinoma cell lineBiochemical and Biophysical Research Communications, 1990
- PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomasCell, 1990
- Activation of a novel human transforming gene, ret, by DNA rearrangementCell, 1985